Weekly CEO Sells Highlight: Cameron International, Envision Healthcare Holdings, Vanda Pharmaceuticals, TCF Financial

A roundup of recent insider sales

Author's Avatar
Sep 20, 2015
Article's Main Image

According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Cameron International Corp., Envision Healthcare Holdings Inc., Vanda Pharmaceuticals Inc. and TCF Financial Corp.

Cameron International Corp. (CAM, Financial): Chairman, President & CEO Jack B. Moore sold 177,452 shares

Chairman, president and CEO of Cameron International Jack B. Moore sold 177,452 shares on Sept. 11 at an average price of $64.09. Cameron International, a Delaware corporation, was incorporated on Nov. 10, 1994. Cameron International has a market cap of $12.2 billion; its shares were traded at around $63.70 with a P/E ratio of 18.80 and P/S ratio of 1.25. Cameron International had an annual average earnings growth of 16.70% over the past 10 years. GuruFocus rated Cameron International Corp the business predictability rank of 4-star.

Cameron International released net sales of $2.22 billion and net earnings of $155 million in its 2015 second quarter results.

Moore sold 177,452 shares of CAM stock on Sept. 11 at the average price of $64.09. Vice president Douglas E. Meikle sold 261 shares of CAM stock on Sept. 10 at the average price of $64.43.

Envision Healthcare Holdings Inc. (EVHC, Financial): Chairman, president and CEO William A. Sanger sold 175,000 shares

Sanger sold 175,000 shares on Sept. 14 at an average price of $41.06. Envision Healthcare Holdings was incorporated on Feb. 28, 2011 in Delaware. Envision Healthcare Holdings has a market cap of $7.9 billion; its shares were traded at around $42.51 with a P/E ratio of 43.30 and P/S ratio of 1.65.

Envision Healthcare Holdings recognized net revenues of $1.4 billion and net income of $52.4 million in its 2015 second quarter financial report.

Sanger sold 768,500 shares of EVHC stock in April, August, and September. EVP, COO and CFO Randel G Owen sold 160,000 shares of EVHC stock in September and August. Chief Medical Officer Dighton Packard, Director Leonard M Riggs, and President of AMR Horne Edward Van together sold 314,000 shares of EVHC stock in April, June, and August.

Vanda Pharmaceuticals Inc. (VNDA, Financial): President and CEO Mihael Hristos Polymeropoulos sold 131,739 shares

Hristos Polymeropoulos sold 131,739 shares on Sept. 10 at an average price of $12.68. Vanda Pharmaceuticals was incorporated in Delaware in 2002 and began operations in March 2003. Vanda Pharmaceuticals has a market cap of $595.802 million; its shares were traded at around $14.09 with a P/E ratio of 12.50 and P/S ratio of 7.15.

Vanda Pharmaceuticals reported its 2015 second quarter results. The company declared net loss of $5.4 million and revenues of $27.6 million.

TCF Financial (TCB, Financial): Chairman and CEO William Allen Cooper sold 100,000 shares

Cooper sold 100,000 shares on Sept. 15 at an average price of $15.6. TCF Financial is a national bank holding company based in Wayzata, Minnesota. TCF has a market cap of $2.51 billion; its shares were traded at around $14.82 with a P/E ratio of 16.40 and P/S ratio of 1.95. The dividend yield is 1.35%.

TCF Financial announced its 2015 second financial quarter results with net sales of $319.5 million and net income of $92.1 million.

Cooper bought 40,000 shares of TCB stock in May and April and sold 100,000 shares in September. Senior Vice President Barbara E. Shaw, Director Barry N. Winslow, Director Peter Bell, and Vice Chair and EVP Thomas F. Jasper together sold 222,098 shares of TCB stock in May, June, and August.

For the complete list of stocks that bought by their CEOs, go to: Insider Buys.